SLC1A2 and Alzheimer disease: Several studies have reported a reduction of GLT-1in the brain of AD patients,,, however all of these reports used post-mortem AD brains with themajority of samples at Braak stages V and VI, thus downregulationof GLT-1 observed here can be a consequence of extensive neurodegenerationin the brain.